摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E) Methyl-4-[6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl]-but-2-enoate | 449209-18-1

中文名称
——
中文别名
——
英文名称
(E) Methyl-4-[6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl]-but-2-enoate
英文别名
methyl (E)-4-[6-[(4-methoxyphenyl)methylcarbamoyl]-1-methyl-2,4-dioxoquinazolin-3-yl]but-2-enoate
(E) Methyl-4-[6-(4-methoxy-benzylcarbamoyl)-1-methyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl]-but-2-enoate化学式
CAS
449209-18-1
化学式
C23H23N3O6
mdl
——
分子量
437.452
InChiKey
DYMYIYFXUNBCNK-SNAWJCMRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    32
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    105
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • Quinazolines as MMP-13 inhibitors
    申请人:——
    公开号:US20020193377A1
    公开(公告)日:2002-12-19
    A compound selected from those of formula (I): 1 in which: R 1 represents a group selected from hydrogen, amino, alkyl, alkenyl, aminoalkyl, aryl, arylalkyl, heterocycle, and cycloalkylalkyl, optionally substituted, W represents oxygen, sulfhur, or ═N—R′, in which R′ is as defined in the description, X 1 , X 2 and X 3 represent nitrogen or —C—R 6 in which R 6 is as defined in the description, Y represents oxygen, sulfhur, —NH, or —N(C 1 -C 6 )alkyl, Z represents oxygen, sulfhur, —NR 7 in which R 7 is as defined in the description, and 59 optionally carbon atom, n is an integer from 1 to 8 inclusive, Z 1 represents —CR 8 R 9 wherein R 8 and R 9 are as defined in the description, A represents aromatic or non-aromatic, heterocyclic or non-heterocyclic ring system, m is an integer from 0 to 7 inclusive, the group(s) R 2 is (are) is as defined in the description, R 3 represents hydrogen, alkyl, alkenyl, alkynyl, ot a group of formula: 2 in which Z 2 , B, R 5 , P and q are as defined in the description, optionally, the racemic forms thereof, isomers thereof, N-oxydes thereof, and the pharmaceutically acceptable salts thereof, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix metalloprotease.
    从以下化学式(I)中选择的一种化合物: 其中: R1代表从氢、基、烷基、烯基、基烷基、芳基、芳基烷基、杂环和环烷基烷基中选择的基团,可选择取代; W代表氧、或═N—R′,其中R′如描述中定义; X1、X2和X3代表氮或—C—R6,其中R6如描述中定义; Y代表氧、、—NH或—N(C1-C6)烷基; Z代表氧、、—NR7,其中R7如描述中定义,且可选地是碳原子; n为1到8之间的整数; Z1代表—CR8R9,其中R8和R9如描述中定义; A代表芳香或非芳香、杂环或非杂环环系统; m为0到7之间的整数; R2代表如描述中定义的基团; R3代表氢、烷基、烯基、炔基或化学式2中的基团: 其中Z2、B、R5、P和q如描述中定义; 可选地,它们的外消旋体、异构体、N-氧化物和药学上可接受的盐,以及含有它们的药物制剂,可用作特异性抑制剂13型基质蛋白酶
查看更多